Distinct expression profile of key molecules in crawling-type early gastric carcinoma
- 12 October 2016
- journal article
- research article
- Published by Springer Nature in Gastric Cancer
- Vol. 20 (4) , 612-619
Abstract
Background Gastric “crawling-type” adenocarcinoma (CRA) is a tumor histologically characterized by irregularly fused glands with low-grade cellular atypia that tends to spread laterally in the mucosa. To date, the expression characteristics of the key molecules involved in CRA, including receptor tyrosine kinases (RTKs), mismatch repair (MMR) proteins, phosphatase and tensin homolog (PTEN), as well as the Epstein–Barr virus (EBV) status, have yet to be uncovered. Methods We constructed tissue microarrays of 94 CRAs, 72 conventional-type differentiated adenocarcinomas (CDAs), and 71 intramucosal poorly cohesive adenocarcinomas (PCAs) from early gastric cancers to evaluate and compare the pathological and expression profiles of potential key molecules for molecular classification (EBV; four MMR proteins–MLH1, MSH2, PMS2, and MSH6; three RTKs–HER2, MET, and EGFR; PTEN; and p53). Results None of the CRAs showed MMR deficiency (0.0 % vs. 5.6 %, CRA vs. CDA, p = 0.036), HER2 overexpression (0.0 % vs. 12.5 %, p = 0.001), or loss of PTEN expression (0.0 % vs. 9.7 %, p = 0.003). Moreover, MET overexpression (4.4 % vs. 19.4 %, p = 0.004), and a mutant p53 pattern (12.4 % vs. 62.5 %, p < 0.001) were significantly less common in CRAs than in CDAs. However, clinicopathological features and all the profile of the molecules of CRAs were close to those of the PCA group. Conclusions CRA demonstrated unique clinicopathological characteristics and showed a distinct expression profile of key molecules, which was close to that of a null phenotype. These results support the classification of CRA as a distinct subgroup of gastric adenocarcinoma.Keywords
Funding Information
- Basic Science Research Program through the National Research Foundation (NRF) of Korea and the Ministry of Science, ICT and Future Planning (2012R1A1A1004403)
- a faculty research grant of Yonsei University College of Medicine (6-2012-0044)
This publication has 18 references indexed in Scilit:
- Very well-differentiated gastric carcinoma of intestinal type: analysis of diagnostic criteriaLaboratory Investigation, 2013
- Physiological roles of Rho and Rho effectors in mammalsEuropean Journal of Cell Biology, 2013
- Gastric extremely well-differentiated intestinal-type adenocarcinoma: a challenging lesion to achieve complete endoscopic resectionEndoscopy, 2012
- HER2 testing in gastric cancer: a practical approachLaboratory Investigation, 2012
- PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer PatientsClinical Cancer Research, 2011
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysisLaboratory Investigation, 2011
- Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast CarcinomaAmerican Journal of Surgical Pathology, 2010
- Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomachGastric Cancer, 2006
- Biopsy Interpretation in Diagnosis of Gastric Carcinoma1993
- Mutational Spectra and Immunohistochemical Analyses of p53 in Human CancersChest, 1992